학술논문

Ibrexafungerp demonstrates in vitro activity against fluconazole-resistant Candida auris and in vivo efficacy with delayed initiation of therapy in an experimental model of invasive Candidiasis
Document Type
Article
Source
In: Antimicrobial Agents and Chemotherapy. (Antimicrobial Agents and Chemotherapy, June 2021, 65(6))
Subject
Language
English
ISSN
10986596
00664804